Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...

The sequence of amino acids in the chain determines how the chain will fold up to make the protein, so different ... take up glucose from the blood and Glucagon: released from pancreas, stimulates ...

(RTTNews) - OPKO Health (OPK) and Entera Bio have entered a collaboration and license agreement to develop the first oral dual agonist GLP-1/glucagon peptide for obesity, metabolic, and fibrotic ...

Glucagon-like peptide 1 (GLP-1), secreted by the intestine when nutrients enter the gut, is one such putative satiety signal. To investigate whether leptin enhances the anorexic effects of GLP-1 ...

Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to ...

Its structure comprises a sequence of amino ... may activate receptors involved in energy balance, such as the glucagon-like peptide-1 (GLP-1) receptor, glucagon receptor (GCGR), and glucose ...

(RTTNews) - OPKO Health (OPK) and Entera Bio (ENTX), Monday announced a collaboration to develop the first oral dual GLP-1/glucagon peptide for obesity, metabolic, and fibrotic disorders.